Plasma total cysteine and cardiovascular risk burden: Action and interaction

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  De Chiara, Benedetta ^a   Sedda, Valentina ^a   Parolini, Marina ^a   Campolo, Jonica ^a   De Maria, Renata ^a   Caruso, Raffaele ^a   Pizzi, Gianluigi ^a   Disoteo, Olga ^a   Dellanoce, Cinzia ^a   Corno, Anna Rosa ^a   Cighetti, Giuliana ^b   Parodi, Oberdan ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTHIOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYSTEINE; CYSTEINYLGLYCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUTATHIONE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MALONALDEHYDE; DIPEPTIDE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; CLASSIFICATION; MIDDLE AGED; OXIDATION REDUCTION REACTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CYSTEINE; DIABETES COMPLICATIONS; DIPEPTIDES; FEMALE; GLUTATHIONE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84861072072     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/303654     Document Type: Article

References (32)

1. Takeuchi M., Yoshitani H., Miyazaki C., Yoshikawa J., Relationship between the number of coronary risk factors and coronary atherosclerosis assessed by high-frequency transthoracic echocardiography Journal of the American Society of Echocardiography 2006 19 8 1056 1062 (Pubitemid 44118698)
2. Harrison D., Griendling K. K., Landmesser U., Hornig B., Drexler H., Role of oxidative stress in atherosclerosis The American Journal of Cardiology 2003 91 3 7A 11A (Pubitemid 36351457)
3. Woodward M., Rumley A., Rumley A., Rumley C., Lewington S., Morrison C. E., Lowe G. D. O., The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study Blood Coagulation and Fibrinolysis 2006 17 1 1 5 (Pubitemid 43170746)
4. Patterson R. A., Lamb D. J., Leake D. S., Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper Atherosclerosis 2003 169 1 87 94 (Pubitemid 36830926)
5. Patel R. S., Al Mheid I., Morris A. A., Ahmed Y., Kavtaradze N., Ali S., Dabhadkar K., Brigham K., Hooper W. C., Alexander R. W., Jones D. P., Quyyumi A. A., Oxidative stress is associated with impaired arterial elasticity Atherosclerosis 2011 218 1 90 95
6. Xiao Y., Zhang Y., Lv X., Su D., Li D., Xia M., Qiu J., Ling W., Ma J., Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects Lipids in Health and Disease 2011 10 137
7. El-Khairy L., Ueland P. M., Refsum H., Graham I. M., Vollset S. E., Plasma total cysteine as a risk factor for vascular disease: the European concerted action project Circulation 2001 103 21 2544 2549 (Pubitemid 32521962)
8. Jones D. P., Mody V. C. Jr., Carlson J. L., Lynn M. J., Sternberg P., Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses Free Radical Biology and Medicine 2002 33 9 1290 1300 (Pubitemid 35246597)
9. American Psychiatric Association, American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1987 3rd Washington, DC, USA
10. Fossati R., Apolone G., Negri E., Compagnoni A., La Vecchia C., Mangano S., Clivio L., Garattini S., A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care Archives of Internal Medicine 2007 167 16 1791 1797 (Pubitemid 47403068)
11. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report Journal of the American Medical Association 2003 289 19 2560 2572 (Pubitemid 37430158)
12. National Cholesterol Education Program (NCEP), Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 2002 106 3143 3421
13. Malinow M. R., Homocyst(e)ine, vitamins and genetic interactions in vascular disease Canadian Journal of Cardiology 1999 15 31B 34B
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 2003 26 1 S5 S20
15. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee 1995 854, 1-452 World Health Organization
16. De Chiara B., Bigi R., Campolo J., Parolini M., Turazza F., Masciocco G., Frigerio M., Fiorentini C., Parodi O., Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients Clinical Transplantation 2005 19 3 367 371 (Pubitemid 40711972)
17. Accinni R., Parodi O., Drew A. F., Determination of plasma homocysteine Atherosclerosis: Experimental Methods and Protocols 2000 52 Humana Press 77 103
18. Accinni R., Campolo J., Bartesaghi S., De Leo G., Lucarelli C., Cursano C. F., Parodi O., High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards Journal of Chromatography A 1998 828 1-2 397 400 (Pubitemid 29046439)
19. Cighetti G., Debiasi S., Paroni R., Allevi P., Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection Analytical Biochemistry 1999 266 2 222 229 (Pubitemid 29047484)
20. Yusuf H. R., Giles W. H., Croft J. B., Anda R. F., Casper M. L., Impact of multiple risk factor profiles on determining cardiovascular disease risk Preventive Medicine 1998 27 1 1 9 (Pubitemid 28362981)
21. Saez G., Thornalley P. J., Hill H. A. O., The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes Biochimica et Biophysica Acta 1982 719 1 24 31 (Pubitemid 13223068)
22. Jia L., Furchgott R. F., Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor Journal of Pharmacology and Experimental Therapeutics 1993 267 1 371 378 (Pubitemid 23325030)
23. Hogg N., The effect of cyst(e)ine on the auto-oxidation of homocysteine Free Radical Biology and Medicine 1999 27 1-2 28 33 (Pubitemid 29353080)
24. Muniz P., Sez P., Iradi A., Via J., Oliva M. R., Sez G. T., Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage Free Radical Biology and Medicine 2001 30 4 354 362 (Pubitemid 32155534)
25. Parodi O., De Chiara B., Baldassarre D., Parolini M., Caruso R., Pustina L., Parodi G., Campolo J., Sedda V., Baudo F., Sirtori C., Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction Clinical Biochemistry 2007 40 3-4 188 193 (Pubitemid 46108700)
26. El-Khairy L., Ueland P. M., Nygrd O., Refsum H., Vollset S. E., Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study 13 The American Journal of Clinical Nutrition 1999 70 6 1016 1024
27. Jacob N., Bruckert E., Giral P., Foglietti M. J., Turpin G., Cysteine is a cardiovascular risk factor in hyperlipidemic patients Atherosclerosis 1999 146 1 53 59 (Pubitemid 29371861)
28. Moat S. J., Bonham J. R., Powers H. J., Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine- meadited vascular disease Clinical Science 2001 100 1 73 79 (Pubitemid 32057811)
29. Jones D. P., Carlson J. L., Mody V. C., Cai J., Lynn M. J., Sternberg P., Redox state of glutathione in human plasma Free Radical Biology and Medicine 2000 28 4 625 635 (Pubitemid 30136044)
30. Tingberg E., hlin A.-K., Gottster A., hlin H., Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy International Journal of Cardiology 2006 112 3 275 281 (Pubitemid 44415048)
31. Chin B. S. P., Langford N. J., Nuttall S. L., Gibbs C. R., Blann A. D., Lip G. Y. H., Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure European Journal of Heart Failure 2003 5 2 171 174 (Pubitemid 36383625)
32. Ashfaq S., Abramson J. L., Jones D. P., Rhodes S. D., Weintraub W. S., Hooper W. C., Vaccarino V., Harrison D. G., Quyyumi A. A., The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults Journal of the American College of Cardiology 2006 47 5 1005 1011